Scientific Reports (Nov 2022)

SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding

  • Pierre Dudouet,
  • Philippe Colson,
  • Sarah Aherfi,
  • Anthony Levasseur,
  • Mamadou Beye,
  • Jeremy Delerce,
  • Emilie Burel,
  • Philippe Lavrard,
  • Wahiba Bader,
  • Jean-Christophe Lagier,
  • Pierre-Edouard Fournier,
  • Bernard La Scola,
  • Didier Raoult

DOI
https://doi.org/10.1038/s41598-022-22060-z
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 13

Abstract

Read online

Abstract At the time of a new and unprecedented viral pandemic, many questions are being asked about the genomic evolution of SARS-CoV-2 and the emergence of different variants, leading to therapeutic and immune evasion and survival of this genetically highly labile RNA virus. The nasopharyngeal persistence of infectious virus beyond 17 days proves its constant interaction with the human immune system and increases the intra-individual mutational possibilities. We performed a prospective high-throughput sequencing study (ARTIC Nanopore) of SARS-CoV-2 from so-called "persistent" patients, comparing them with a non-persistent population, and analyzing the quasi-species present in a single sample at time t. Global intra-individual variability in persistent patients was found to be higher than in controls (mean 5.3%, Standard deviation 0.9 versus 4.6% SD 0.3, respectively, p < 0.001). In the detailed analysis, we found a greater difference between persistent and non-persistent patients with non-severe COVID 19, and between the two groups infected with clade 20A. Furthermore, we found minority N501Y and P681H mutation clouds in all patients, with no significant differences found both groups. The question of the SARS-CoV-2 viral variants’ genesis remains to be further investigated, with the need to prevent new viral propagations and their consequences, and quasi-species analysis could be an important key to watch out.